GURU.Markets stock price, segment price, and overall market index valuation
The company's share price TELA Bio Inc.
TELA Bio is a company that produces medical devices made from biological materials for soft tissue reconstruction. Its stock price reflects the adoption of its products in surgical practice. The chart shows a growth story driven by the displacement of synthetic materials.
Share prices of companies in the market segment - Therapeutic medical equipment
TELA Bio is a medical device company that develops and markets tissue matrices for soft tissue reconstruction, such as in hernia and breast surgeries. We've classified it in the "Therapeutic Medical Equipment" segment. The graph below shows the overall dynamics in the surgical materials sector, where innovation is improving treatment outcomes.
Broad Market Index - GURU.Markets
TELA Bio is a medical device company that produces and markets soft tissue reconstruction materials used in surgery. It is a component of the GURU.Markets index. The chart below represents the market. See how this company's stock compares to the medical technology sector.
Change in the price of a company, segment, and market as a whole per day
TELA - Daily change in the company's share price TELA Bio Inc.
TELA Bio, Inc.'s daily stock price fluctuations reflect the volatility of the reconstructive medical supplies sector. This metric measures the company's sensitivity to sales data and clinical outcomes for its products.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
TELA Bio, Inc. is a company in the medical technology sector. This chart illustrates the high volatility of the MedTech industry. Comparing this to TELA, which focuses on reconstructive surgery, helps us understand how its innovative products contribute to its volatility.
Daily change in the price of a broad market stock, index - GURU.Markets
TELA Bio produces innovative biomaterials for reconstructive surgery. This medtech company's stock price reflects the demand for advanced medical solutions. Its share price movement reflects the contribution of innovative medicine to overall market volatility, which you can see on the chart.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization TELA Bio Inc.
For TELA Bio, Inc., year-over-year performance is a story of growth in the reconstructive surgery market. Its 12-month market cap growth reflects the growing number of surgeons using its polymer and animal tissue meshes for hernia repair and breast reconstruction, its core niche.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
TELA Bio, Inc. is a commercial medical device company specializing in soft tissue reconstruction products. This chart shows how its innovative products, growing hospital adoption, and competition in the medical device sector impact its growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
TELA Bio, a medical device manufacturer, operates in the protective sector. Demand for its products is driven by medical needs, not the state of the economy. The company's stock performance reflects its success in innovation and sales, making it a non-cyclical growth story, isolated from general market cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization TELA Bio Inc.
TELA Bio manufactures and sells medical devices for soft tissue reconstruction. Its monthly growth reflects the rate of adoption of its products by surgeons. Quarterly reports on revenue growth and the number of procedures performed are the main drivers of its value.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
The soft tissue reconstruction market is a segment where innovative materials have the potential to change surgical standards. Its market capitalization dynamics, shown in the graph, reflect the demand for new technologies. In this environment, companies like TELA Bio are commercializing their products.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
TELA Bio, a manufacturer of medical materials for soft tissue reconstruction, is benefiting from demand for innovative surgical solutions. The company's shares are poised to outperform the market thanks to increased adoption of its products, keeping pace with medical innovation.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization TELA Bio Inc.
Short-term fluctuations in TELA Bio, a manufacturer of soft tissue reconstruction medical devices, reflect the pace of their adoption by surgeons. Sales growth data, as well as comparisons with competitors' products, shape short-term investor sentiment.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
TELA Bio and the entire surgical medical device sector respond to general hospital procurement cycles. Hospital budgets and insurance company policies are drivers for everyone. The chart shows how a niche player compares to industry giants.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
TELA Bio and the entire surgical medical device sector respond to general hospital procurement cycles. Hospital budgets and insurance company policies are drivers for everyone. The chart shows how a niche player compares to industry giants.
Market capitalization of the company, segment and market as a whole
TELA - Market capitalization of the company TELA Bio Inc.
TELA Bio's market capitalization is the financial valuation of a company that produces medical devices made from natural materials for soft tissue reconstruction. The chart reflects demand for its products as an alternative to synthetic mesh. Its dynamics tell a story about how investors view sales growth and the adoption of its technology in surgical practice.
TELA - Share of the company's market capitalization TELA Bio Inc. within the market segment - Therapeutic medical equipment
TELA Bio develops and markets medical devices made from biological materials for soft tissue reconstruction, such as hernia repair. Its market share reflects its innovative approach and competition from synthetic materials. The chart below shows its market share in the surgical materials market.
Market capitalization of the market segment - Therapeutic medical equipment
TELA Bio manufactures and markets surgical meshes made from natural materials for soft tissue reconstruction. The graph below shows the overall market capitalization of the therapeutic equipment sector. Its growth reflects the search for safer and more effective materials. TELA Bio products offer an alternative to synthetic meshes.
Market capitalization of all companies included in a broad market index - GURU.Markets
The surgical materials shown in the graph are constantly being improved. TELA Bio produces implants from bovine and porcine tissue for soft tissue repair, such as hernia repair. Its capitalization is a bet that its semi-synthetic materials will offer better results than existing meshes.
Book value capitalization of the company, segment and market as a whole
TELA - Book value capitalization of the company TELA Bio Inc.
TELA Bio's book value is the raw material base for the creation of improved surgical materials. The chart reflects the value of its manufacturing facilities, which produce fabric meshes for reconstructive surgery that combine the strength of synthetic materials with biocompatibility.
TELA - Share of the company's book capitalization TELA Bio Inc. within the market segment - Therapeutic medical equipment
TELA Bio manufactures and markets innovative products for soft tissue reconstruction. Its stake in the sector's assets lies in specialized manufacturing facilities. This physical base allows it to create products that combine biological and synthetic materials to improve surgical outcomes.
Market segment balance sheet capitalization - Therapeutic medical equipment
TELA Bio, Inc. produces medical materials for soft tissue reconstruction. Its business is moderately capital-intensive. The company requires manufacturing capacity to create its bio-implants. Compared to the medical device sector, this demonstrates that the production of innovative materials requires control over physical assets.
Book value of all companies included in the broad market index - GURU.Markets
TELA Bio's assets are more than just implants; they are innovative tissue matrices that combine biological and synthetic materials for reconstructive surgery. The company's balance sheet reflects the value of this unique technology. The chart shows the capital behind the development of more advanced tissue repair materials.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - TELA Bio Inc.
TELA Bio produces medical devices for soft tissue reconstruction. Its market capitalization is based on its patented products, which offer superior clinical outcomes. Investors pay a premium for its innovation and growing market share in the conservative surgical materials market.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
TELA Bio manufactures and markets medical devices for soft tissue reconstruction. Its value lies in its unique products, which it claims are superior to traditional ones. This chart shows the market premium it pays for its innovative materials and its potential to gain market share in conservative surgical procedures.
Market to book capitalization ratio for the market as a whole
TELA Bio manufactures and markets medical devices made from biomaterials for soft tissue reconstruction. As a medtech company, its valuation is based on its unique technology and patents. This chart demonstrates the high premium investors pay for innovative medical products that offer superior clinical outcomes.
Debts of the company, segment and market as a whole
TELA - Company debts TELA Bio Inc.
TELA Bio develops and markets medical devices for soft tissue reconstruction. Growth in the medical device market requires significant investments in clinical data, marketing, and surgeon training. Debt financing helps the company accelerate the commercialization and adoption of its products in hospitals.
Market segment debts - Therapeutic medical equipment
TELA Bio, Inc. manufactures and markets medical devices for soft tissue reconstruction. After entering the market, the company needs to invest in its sales team and marketing to compete with established players. This chart shows how TELA Bio is funding its commercial expansion and how its debt policy supports its growth strategy.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio TELA Bio Inc.
TELA Bio produces innovative medical materials for surgery. This chart shows how the company finances its production and market entry. For a medical device manufacturer, debt may be necessary for scaling, but it becomes a risk if the product fails to gain widespread acceptance among surgeons or faces strong competition.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
TELA Bio develops and markets medical devices based on biological materials for soft tissue reconstruction, offering an alternative to synthetic mesh. This chart compares the company's debt to the total market capitalization of the entire therapeutic medical device sector. It helps assess how the company finances the implementation of its innovative materials in surgery.
Debt to book value of all companies in the market
TELA Bio specializes in the production and sale of innovative materials for reconstructive surgery. Capturing market share in medical devices requires investment in sales and marketing. The chart shows how the company leverages its growth and how its strategy compares to other medical device manufacturers.
P/E of the company, segment and market as a whole
P/E - TELA Bio Inc.
For TELA Bio, a company that produces medical devices for soft tissue reconstruction, this chart is an assessment of its technology. The price-to-earnings ratio shows whether investors believe its products are superior to existing synthetic meshes. The price-to-earnings ratio reflects the speed of acceptance by surgeons and sales growth.
P/E of the market segment - Therapeutic medical equipment
This chart shows the average valuation for medical device manufacturers—a benchmark for TELA Bio. Comparing this metric helps investors understand how the market views the company's technology and its growth potential compared to competitors. A higher-than-average valuation may indicate confidence in the superiority of its products.
P/E of the market as a whole
TELA Bio develops and markets medical devices made from biological materials for soft tissue reconstruction, such as in hernia surgeries. The company offers an alternative to synthetic mesh. This chart reflects the state of the medical technology sector. It helps understand how doctors and hospitals are adopting this new technology and how this impacts TELA Bio's growth rate and valuation.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company TELA Bio Inc.
TELA Bio develops and markets tissue materials for reconstructive surgery, such as hernia repair. The company's future profitability depends on surgeons' preference for its products over synthetic mesh. This chart shows analysts' confidence in the clinical benefits and commercial potential of TELA Bio's materials.
%20P%2FE%20TELA%20Bio%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-TELA-Bio-Inc.&v=1772617273956 "Chart of the company's future (projected) P/E TELA Bio Inc.")
Future (projected) P/E of the market segment - Therapeutic medical equipment
TELA Bio develops and markets medical devices based on biological materials for soft tissue reconstruction, such as hernia repair. The chart shows how the company's revenue forecast compares to the medical device industry average. This reflects the market's perception of its technology, which offers an alternative to synthetic mesh and human tissue.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Therapeutic-medical-equipment&v=1772617273977 "Future (projected) P/E graph of the market segment - Therapeutic medical equipment")
Future (projected) P/E of the market as a whole
TELA Bio is a company that produces medical devices based on biological materials for soft tissue reconstruction. This chart reflects the overall sentiment in the healthcare sector. For TELA, the focus isn't so much on economics as on the acceptance of their products by surgeons and reimbursement from insurance companies. This is a growth story based on offering the best clinical solutions.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772617273992 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit TELA Bio Inc.
TELA Bio develops and markets medical devices for soft tissue reconstruction using a combination of biological and synthetic materials. This chart shows the company's financial performance, which aims to improve surgical outcomes, such as hernia repair. Profitability depends on the acceptance of its products by surgeons.
Profit of companies in the market segment - Therapeutic medical equipment
TELA Bio is a company that develops and markets medical devices made from biological materials for soft tissue reconstruction, such as hernia and breast reconstruction. This chart shows the overall profitability of the therapeutic device sector, demonstrating how innovative materials and approaches are being applied in surgery and improving treatment outcomes.
Overall market profit
TELA Bio manufactures and markets medical devices for soft tissue reconstruction. Demand for its products is driven by surgical procedures and is independent of economic cycles. Hospitals have a constant need for these materials, ensuring TELA Bio a stable income even during periods of general economic instability.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company TELA Bio Inc.
TELA Bio develops and markets medical devices based on biological materials for reconstructive surgery, such as hernia repair. This chart reflects analysts' expectations for how successfully its products will compete with synthetic alternatives and gain market share.
%20profit%20of%20the%20company%20TELA%20Bio%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-TELA-Bio-Inc.&v=1772617274058 "Graph of future (projected) profit of the company TELA Bio Inc.")
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
TELA Bio specializes in the development and sale of soft tissue reconstruction products using both biological and synthetic materials. This chart shows forecasts for the medical technology sector. TELA Bio's profitability depends on surgeons' acceptance of its innovative products, which offer improved outcomes compared to existing solutions.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Therapeutic-medical-equipment&v=1772617274150 "Graph of future (predicted) profits of companies in a market segment - Therapeutic medical equipment")
Future (predicted) profit of the market as a whole
TELA Bio, Inc. develops and markets medical devices for soft tissue reconstruction. Demand for its products depends on the number of elective surgeries, which can decline during periods of economic instability. This graph, showing corporate profit projections, is an indicator of the health of the economy, which influences hospital budgets and patient decisions.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772617274196 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - TELA Bio Inc.
TELA Bio develops and markets medical devices made from biological materials for soft tissue reconstruction. This chart shows how investors value its revenue, which challenges traditional synthetic implants. It reflects confidence in the advantages of its products and their growing use in surgery.
P/S market segment - Therapeutic medical equipment
TELA Bio develops and markets medical devices made from biological materials for soft tissue reconstruction, such as hernia repair. Its products offer an alternative to synthetic mesh. This chart shows the average rating for medical device manufacturers, helping to understand how the market values the innovative approach and commercial prospects of TELA Bio's products.
P/S of the market as a whole
TELA Bio develops and markets medical devices made from biological materials for soft tissue reconstruction. The company's products offer an alternative to synthetic mesh. This chart shows the premium investors are willing to pay for the revenue of a company that offers innovative and potentially safer surgical solutions.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company TELA Bio Inc.
TELA Bio develops and markets medical devices based on biological materials for soft tissue reconstruction, such as hernia repair. This graph reflects the company's investment expectations for future revenue. It is closely linked to the growth in the number of surgical procedures and the acceptance of its innovative products by surgeons.
%20P%2FS%20TELA%20Bio%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-TELA-Bio-Inc.&v=1772617274400 "The graph of the company's future (projected) P/S TELA Bio Inc.")
Future (projected) P/S of the market segment - Therapeutic medical equipment
TELA Bio develops and markets medical devices made from biological materials for soft tissue reconstruction. This chart compares the company's estimated future sales with its industry. It reflects the market's assessment of the advantages of its products compared to synthetic alternatives and their acceptance by surgeons.
%20P%2FS%20market%20segment%20graph%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Therapeutic-medical-equipment&v=1772617274439 "Future (projected) P/S market segment graph - Therapeutic medical equipment")
Future (projected) P/S of the market as a whole
TELA Bio is a company developing and marketing medical devices based on biological materials for soft tissue reconstruction. This chart illustrates general expectations, and TELA Bio represents innovation in surgery. The company's growth is an indicator of the demand for more advanced and biocompatible materials to improve surgical outcomes.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772617274483 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales TELA Bio Inc.
TELA Bio develops and markets medical devices for soft tissue reconstruction using both biological and synthetic materials. Revenue, shown in this chart, is generated from sales of these products to hospitals for use in hernia and plastic surgery. Growth reflects the adoption of its technology by surgeons.
Sales of companies in the market segment - Therapeutic medical equipment
TELA Bio develops and markets innovative soft tissue reconstruction products using both biological and synthetic materials. Their solutions are used in hernia and plastic surgery. This chart illustrates the growing medical device market, where advanced materials like TELA Bio's help improve surgical outcomes.
Overall market sales
TELA Bio, Inc. manufactures and markets biobased medical devices for soft tissue reconstruction. The growth in overall revenue, reflected in this graph, contributes to the increase in elective surgical procedures. Hospitals receive better funding, allowing them to utilize more advanced and effective materials, such as TELA Bio products.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company TELA Bio Inc.
TELA Bio, Inc. develops and markets innovative soft tissue medical devices for surgical repair, such as hernia repair. The company's products combine biological and synthetic materials. This chart shows analysts' expectations for the adoption of its products in surgical practice and market share.
%20sales%20of%20the%20company%20TELA%20Bio%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-TELA-Bio-Inc.&v=1772617274522 "Schedule of future (projected) sales of the company TELA Bio Inc.")
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
TELA Bio develops and markets tissue matrices for reconstructive surgery, such as hernia repair and soft tissue reconstruction. The company's products offer a more natural alternative to synthetic meshes. This chart shows forecasts for the medical device sector, illustrating the demand for innovative and safe surgical solutions.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Therapeutic-medical-equipment&v=1772617274565 "Schedule of future (projected) sales of companies in the market segment - Therapeutic medical equipment")
Future (projected) sales of the market as a whole
TELA Bio, a manufacturer of biomaterials for reconstructive surgery, sees this chart as an indicator of the number of elective surgeries. The economic growth reflected here means more people have insurance and can afford elective procedures like hernia repair, which directly increases demand for the company's products.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772617274585 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality TELA Bio Inc.
TELA Bio develops and markets medical devices for soft tissue reconstruction using both biological and synthetic materials. The company's profitability depends on the acceptance of its products by surgeons and hospitals. This chart shows the success of commercialization and how revenue from sales of innovative surgical materials translates into net profit.
Market segment marginality - Therapeutic medical equipment
TELA Bio develops and markets soft tissue reconstruction products using biological materials. In the medical device sector, efficiency is determined by production costs and successful commercialization. This chart shows how cost-effective the company's innovative products are compared to competitors' solutions.
Market marginality as a whole
TELA Bio develops and markets medical devices for soft tissue reconstruction using a combination of synthetic and biological materials. Based on its overall profitability, TELA Bio operates in the surgical innovation niche. Their profitability depends on the acceptance of their products by surgeons and their advantages over existing solutions.
Employees in the company, segment and market as a whole
Number of employees in the company TELA Bio Inc.
TELA Bio offers innovative solutions for soft tissue reconstruction. This chart shows the size of its team, a significant portion of which is dedicated to sales. The growth of its sales force is a key indicator of the company's efforts to promote its products to surgeons and increase market share.
Share of the company's employees TELA Bio Inc. within the market segment - Therapeutic medical equipment
TELA Bio develops and manufactures innovative tissue matrices for reconstructive surgery, offering an alternative to synthetic meshes. This chart shows the percentage of specialists—from biomedical engineers to surgical consultants—that TELA Bio attracts in its niche. This is a measure of its innovative contribution and growing presence in the operating room.
Number of employees in the market segment - Therapeutic medical equipment
TELA Bio develops and markets medical devices for soft tissue reconstruction using a combination of biological and synthetic materials. Its success depends on its sales team. This chart shows how the company is growing its sales. The growth of its staff, particularly in the sales department, is an indicator of the acceptance of its products by surgeons.
Number of employees in the market as a whole
TELA Bio produces and markets innovative materials for reconstructive surgery. Demand in the medical technology sector depends on hospital budgets and the number of elective surgeries. The growth in overall employment, visible in this graph, often correlates with the increase in the number of people with health insurance, which is positive for TELA Bio.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company TELA Bio Inc. (TELA)
TELA Bio produces medical devices by combining R&D and manufacturing. This metric reflects the balance between the value of patents and the efficiency of production lines. The graph's dynamics can show how the company's focus is shifting from development to scaling up sales.
%20of%20the%20company%20TELA%20Bio%20Inc.%20(TELA)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-TELA-Bio-Inc.-TELA&v=1772617274743 "Chart of market capitalization per employee (in thousands of dollars) of the company TELA Bio Inc. (TELA)")
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
TELA Bio, Inc. specializes in the development and sale of soft tissue reconstruction products. Innovation and commercialization are crucial in the medical device sector. This chart shows how the market values the company's product portfolio and its ability to sell it per team member compared to other medical device manufacturers.
%20by%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Therapeutic-medical-equipment&v=1772617274773 "Market capitalization per employee (in thousands of dollars) by market segment - Therapeutic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
TELA Bio develops and markets medical devices based on biological materials for soft tissue reconstruction. It is a MedTech company. This chart shows how the market values a business where innovative, patented products and an effective sales team generate high added value per employee.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772617274912 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company TELA Bio Inc. (TELA)
TELA Bio manufactures and sells medical devices (surgical meshes) for soft tissue reconstruction using both biological and synthetic materials. This chart shows how successfully the company commercializes its innovative products. It reflects how much profit each employee (salesperson, engineer) generates in the competitive medical equipment sector.
%20Chart%20TELA%20Bio%20Inc.%20(TELA)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-TELA-Bio-Inc.-TELA&v=1772617274948 "Company Profit Per Employee (in thousands of dollars) Chart TELA Bio Inc. (TELA)")
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
TELA Bio (TELA) is a medical device company specializing in the development and sale of soft tissue reconstruction products (e.g., hernia repair). This chart shows the company's commercial performance. It reflects how successfully the sales and marketing department promotes their specialized medical products to surgeons, generating revenue per employee.
%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Therapeutic-medical-equipment&v=1772617275043 "Chart of profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
TELA Bio is a medical company that develops and sells tissue implants for surgical procedures (for example, for hernias). It is a commercial company, balancing production and sales. This chart shows how successfully the company sells its products. Revenue per employee depends on the margins of the implants and the effectiveness of the sales team working with surgeons and hospitals.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772617275140 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee TELA Bio Inc. (TELA)
TELA Bio develops and markets medical devices for soft tissue reconstruction. This chart shows how well their products are accepted by surgeons. Growing revenue per employee indicates that the company is effectively expanding its market share by offering an innovative alternative to existing solutions.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-TELA-Bio-Inc.-TELA&v=1772617275157 "Sales chart per company employee TELA Bio Inc. (TELA)")
Sales per employee in the market segment - Therapeutic medical equipment
TELA Bio is a MedTech company that develops and markets tissue-based biological materials for reconstructive surgery (e.g., hernia repair). This chart shows the average revenue per employee in the sector. It helps assess how productive TELA's commercial team is in promoting its innovative, but expensive, products to surgeons compared to its competitors.
Sales per employee for the market as a whole
TELA Bio, Inc. (TELA) manufactures and markets medical devices (biomatrixes) for soft tissue reconstruction, such as hernia treatment. This is a high-tech medical product. This chart shows how successfully their sales team promotes these products to hospitals and how much revenue they generate per employee.
Short shares by company, segment and market as a whole
Shares shorted by company TELA Bio Inc. (TELA)
TELA Bio produces medical devices (surgical mesh) from biological materials for soft tissue repair (e.g., hernia repair). This is a competitive medical equipment market. The chart shows the number of investors betting that TELA's products will not displace established synthetic meshes from giants like J&J and Medtronic, limiting its growth.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-TELA-Bio-Inc.-TELA&v=1772617275247 "Short Shares Chart for the Company TELA Bio Inc. (TELA)")
Shares shorted by market segment - Therapeutic medical equipment
TELA Bio produces surgical mesh reinforced with biological material for reconstructive surgeries. This indicator measures bearish sentiment in the sector. It rises when investors anticipate a slowdown in elective surgeries or perceive risks (such as mesh-related lawsuits) that could impact the entire industry.
Shares shorted by the overall market
TELA Bio produces medical materials (meshes) for soft tissue reconstruction. This chart illustrates the overall market pessimism. The company's products are used in elective surgeries. Fear of a recession means hospitals and patients will cut costs by postponing non-critical surgeries, which will reduce demand for TELA materials.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator TELA Bio Inc. (TELA)
This chart for TELA Bio is an indicator of the battle for market share in surgical materials. The company produces innovative meshes for hernia repair and soft tissue reconstruction. When TELA reports an increase in the number of surgeons using its product or strong clinical data, the oscillator moves into an overbought range (above 70). Competition from MedTech giants is holding back growth.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-TELA-Bio-Inc.-TELA&v=1772617275337 "RSI 14 indicator chart for the company's stock TELA Bio Inc. (TELA)")
RSI 14 Market Segment - Therapeutic medical equipment
TELA Bio (TELA) — soft tissue repair. They make *smart* (OviTex) *meshes* (from *sheep* tissue) for *strengthening* during *hernia surgery*. The "Therapeutic medical equipment" (medtech) sector thrives on R&D. RSI_14_Seg shows whether the *entire* sector is "overbought." This helps differentiate: is TELA's growth a niche product or a general "overheating"?
RSI 14 for the overall market
For TELA Bio, whose devices are used in surgery, this chart is an indicator of elective surgeries. During periods of euphoria and stability, patients confidently undergo expensive elective surgeries. During periods of market panic and rising unemployment, people, fearing loss of insurance, postpone "non-urgent" surgeries.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast TELA (TELA Bio Inc.)
TELA Bio (TELA) produces medical devices (surgical meshes) based on natural materials for soft tissue reconstruction (e.g., hernia repair). This chart shows the average 12-month forecast. It reflects analysts' expectations for the rate of adoption of this technology by surgeons and its competition with synthetic meshes.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-TELA-TELA-Bio-Inc.&v=1772617275430 "A chart showing analyst consensus forecasts for the expected stock price. TELA (TELA Bio Inc.)")
The difference between the consensus estimate and the actual stock price TELA (TELA Bio Inc.)
TELA Bio (TELA) is a medical technology company that produces "biomeshes" (OviTex) for reconstructive surgeries (e.g., hernia repair) using sheep tissue. This chart shows the valuation of their technology. It measures the gap between the price and the consensus target, reflecting whether analysts believe their "natural" implants will gain market share from synthetic ones.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-TELA-TELA-Bio-Inc.&v=1772617275591 "A chart showing the difference between the consensus forecast and the actual stock price. TELA (TELA Bio Inc.)")
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
TELA Bio is a medical company developing "biomeshes" (OviTex) based on sheep tissue for reconstructive surgery (e.g., hernia repair). This chart shows general expectations for the therapeutic medical device sector. It reflects whether experts believe in the advantages of "natural" implants over synthetic ones.
Analysts' consensus forecast for the overall market share price
TELA Bio produces cutting-edge products for soft tissue repair (hernia treatment). This chart, showing the collective market forecast, is key. While some procedures are emergency, many are elective. When analysts are optimistic, employment is high (people have insurance). During a recession (pessimism), they are often postponed.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index TELA Bio Inc.
TELA Bio is a MedTech company focused on surgery. They produce bio-mesh (surgical mesh) that uses natural (sheep) tissue for reinforcement in hernia repair and breast reconstruction surgeries. This chart summarizes their growth. It reflects their ability to capture market share from synthetic meshes, demonstrating the superiority of their natural technology.
AKIMA Market Segment Index - Therapeutic medical equipment
TELA Bio (TELA) is a medical device company specializing in soft tissue reconstruction solutions. They offer implants (surgical meshes) based on both animal and polymer tissue. The chart shows the average index for the segment, helping investors assess how TELA competes in the surgical materials market compared to the average.
The AKIM Index for the overall market
TELA Bio is a medtech company specializing in soft tissue repair materials (hernias, plastic surgery). It uses reinforced biological matrices. This chart, which reflects the market average, is a backdrop. It helps assess how this growth story in surgery compares to overall macroeconomic trends and product adoption.
